SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001127855-05-000390
Filing Date
2005-05-27
Accepted
2005-05-27 13:12:19
Documents
10
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 SINOVAC BIOTECH 20-F, 12.31.04 sinovac20f123104.txt 20-F 305972
2 SINOVAC BIOTECH 20-F, NOTE AGREEMENT sinovacexh10_7.txt EX-10.7 49724
3 SINOVAC BIOTECH 20-F, INDEMNITY AGREEMENT sinovacexh10_8.txt EX-10.8 49712
4 SINOVAC BIOTECH 20-F, SHARE PURCHASE AGREEMENT sinovacexh10_9.txt EX-10.9 67146
5 SINOVAC BIOTECH 20-F, COOPERATION AGREEMENT sinovacexh10_10.txt EX-10.10 9492
6 SINOVAC BIOTECH 20-F, COOPERATIVE SERV. AGREEMENT sinovacexh10_11.txt EX-10.11 32226
7 SINOVAC BIOTECH 20-F, CERTIFICATION 302, CEO sinovacexh31_1.txt EX-31.1 4422
8 SINOVAC BIOTECH 20-F, CERTIFICATION 302, CFO sinovacexh31_2.txt EX-31.2 4478
9 SINOVAC BIOTECH 20-F, CERTIFICATION 906, CEO sinovacexh32_1.txt EX-32.1 2246
10 SINOVAC BIOTECH 20-F, CERTIFICATION 906, CFO sinovacexh32_2.txt EX-32.2 2347
  Complete submission text file 0001127855-05-000390.txt   529856
Mailing Address 39 SHANGDI XI ROAD HAIDIAN DISTRICT BEIJING F4 100085
Business Address 39 SHANGDI XI ROAD HAIDIAN DISTRICT BEIJING F4 100085 86-10-82890088
SINOVAC BIOTECH LTD (Filer) CIK: 0001084201 (see all company filings)

IRS No.: 000000000 | State of Incorp.: B9 | Fiscal Year End: 0430
Type: 20-F | Act: 34 | File No.: 001-32371 | Film No.: 05862766
SIC: 2834 Pharmaceutical Preparations